A-Mark Pharma Private Limited

A-Mark Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24233MH2011PTC213660 Incorporated 17 February 2011 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹5.25 Cr
▼ 5% YoY
Net profit · FY 2025
₹86,267
Net margin 0.2%
EBITDA · FY 2025
₹1.71 Lakh
EBITDA margin 0.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About A-Mark Pharma Private Limited

Data last updated:

A-Mark Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PTC213660. Its GSTIN is 27AAJCA5460E1ZR (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Shilpi Mandhana and Suresh Mandhana.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.25 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹86,267 (net margin 0.2%) and EBITDA of ₹1.71 Lakh (EBITDA margin 0.3%).

Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.

A-Mark Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0028147). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24233MH2011PTC213660
Registration Number 213660
Incorporation Date 17 February 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0028147

Recognitions & Rankings of A-Mark Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-19-0028147

Contact details

A-Mark Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    411 Atlanta Estate Premises Co – Op. Society Limited G. M. Link Road Near Virwani Goregaon, (East), Mumbai, Maharashtra, India – 400063
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of A-Mark Pharma Private Limited, buy the company report.

Comprehensive company report
A-Mark Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of A-Mark Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of A-Mark Pharma Private Limited

FY 2025 filings available

A-Mark Pharma Private Limited reported revenue of ₹5.25 Cr (down 5% YoY) for FY 2025.

Revenue · FY 2025
₹5.25 Cr ▼ 5%
Net profit · FY 2025
₹86,267 margin 0.2%
EBITDA · FY 2025
₹1.71 Lakh margin 0.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 5%
EBITDA CAGR growth
1 year
▼ 51%
5 years · compounded
▲ 34%

Revenue fell 5% in the latest year. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.71 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹86,267
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.3%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of A-Mark Pharma Private Limited, buy the company report.

Board of directors of A-Mark Pharma Private Limited

A-Mark Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shilpi MandhanaDirector17 Feb 201115 Years 9 MonthsCurrent
Suresh MandhanaDirector25 Jan 20224 Years 9 MonthsCurrent

Auditor

A-Mark Pharma Private Limited is audited by BAKLIWAL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
BAKLIWAL & COFY 2021130381W

Shareholding

The shareholding of A-Mark Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2019FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of A-Mark Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for A-Mark Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

A-Mark Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAJCA5460E1ZRMaharashtraActive03 Dec 2020

To see the full GST registrations and return filing status of A-Mark Pharma Private Limited, buy the company report.

Recent activity

A-Mark Pharma Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Rohitash Kailashchand Mandhana ceased to be Director on 25 Jan 2022.

AGM
A-Mark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
A-Mark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Rohitash Kailashchand Mandhana ceased to be Director.
Appointed
Suresh Mandhana was appointed as Director.
Appointed
Rohitash Kailashchand Mandhana was appointed as Director.
Appointed
Shilpi Mandhana was appointed as Director.
Incorporation
17 Feb 2011
A-Mark Pharma Private Limited was registered on 17 Feb 2011 with Roc Mumbai I & aged 15 years 9 months as per MCA records.

Frequently asked questions

A-Mark Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2011 (15+ years old) and is registered under CIN U24233MH2011PTC213660.

A-Mark Pharma has 2 current directors:

The latest financial statements of A-Mark Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of A-Mark Pharma is 27AAJCA5460E1ZR, registered in Maharashtra.

The CIN (Corporate Identification Number) of A-Mark Pharma is U24233MH2011PTC213660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

A-Mark Pharma has 3 court cases on record: 3 filed against it. 1 is pending.

A-Mark Pharma was incorporated on 17 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Rohitash Kailashchand Mandhana ceased to be Director on 25 Jan 2022. Suresh Mandhana was appointed as Director on 25 Jan 2022. Rohitash Kailashchand Mandhana was appointed as Director on 17 Feb 2011. A-Mark Pharma has 4 board changes on record in total.

Yes, A-Mark Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0028147).

The registered office of A-Mark Pharma is at 411 Atlanta Estate Premises Co – Op. Society Limited G. M. Link Road Near Virwani Goregaon, East, Mumbai, Maharashtra, India – 400063.